Cibc Asset Management Inc Ascendis Pharma A/S Transaction History

Cibc Asset Management Inc

  • $28.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
BUY
$84.03 - $110.23 $10.8 Million - $14.2 Million
129,064 New
129,064 $13.3 Million
Q4 2021

Feb 08, 2022
SELL
$127.1 - $169.66 $23.3 Million - $31.1 Million
-183,374 Closed
0 $0
Q3 2021

Nov 09, 2021
BUY
$112.67 - $176.92 $2.15 Million - $3.38 Million
19,095 Added 11.62%
183,374 $29.2 Million
Q2 2021

Aug 16, 2021
BUY
$121.62 - $145.29 $20 Million - $23.9 Million
164,279 New
164,279 $21.6 Million

Others Institutions Holding ASND

# of Institutions
244
Shares Held
58.8M
Call Options Held
250K
Put Options Held
377K
View Full List

About Ascendis Pharma A/S

ASND Quotes by TradingView
  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.61B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email